Physician Assistant · Santa Barbara, CA
NPI
1225583735
Since 2016
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2403 Castillo St, Suite 201
Santa Barbara, CA, 93105
Phone (805) 682-3585
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
756 services
Medicare patients, 2024
523
Average age 75
Drug cost, 2024
$1.2M
2,230 prescriptions
Company payments, 2025
$1,556
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel D Catevenis was code 99214 (office e&m - established), 360 times for 245 patients. In total Rachel D Catevenis billed 756 services in 11 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 360 | 245 | $81.06 | $29K |
| 99204 Office E&M - New | Office | 256 | 256 | $105.19 | $27K |
| 99213 Office E&M - Established | Office | 61 | 54 | $56.21 | $3,429 |
| 99203 Office E&M - New | Office | 27 | 27 | $65.93 | $1,780 |
| 91110 Standard X-ray | Office | 13 | 13 | $560.01 | $7,280 |
By year: 2022 $5,612 for 75 services; 2023 $66K for 743 services; 2024 $70K for 756 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rachel D Catevenis prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 999 prescriptions and refills. In total Rachel D Catevenis wrote 2,230 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 999 | 1,010 | 967 | $67K |
| Famotidine Generic | 219 | 386 | 69 | $9,136 |
| Omeprazole Generic | 183 | 365 | 62 | $1,816 |
| Cholestyramine Cholestyramine (With Sugar) | 69 | 135 | 30 | $4,812 |
| Pantoprazole Sodium Generic | 69 | 157 | 26 | $3,056 |
| Ondansetron Odt Ondansetron | 45 | 45 | 24 | $782 |
| Dicyclomine Hcl Generic | 44 | 50 | 14 | $807 |
| Nortriptyline Hcl Generic | 44 | 102 | 17 | $969 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 43 | 47 | 16 | $975 |
| Linzess Linaclotide | 38 | 76 | 15 | $41K |
| Sucralfate Generic | 35 | 39 | 13 | $4,345 |
| Hydrocortisone Generic | 28 | 28 | 24 | $719 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 27 | 27 | 26 | $4,342 |
| Stelara Ustekinumab | 26 | 40 | Under 11 | $684K |
| Balsalazide Disodium Generic | 23 | 38 | Under 11 | $5,596 |
Brand drugs: 287 claims; generic drugs: 1,943 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachel D Catevenis $1,556 ($1,556 in general payments such as food, travel and fees) from 13 companies. The largest payer was Janssen Biotech, Inc. with $317.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 10 | $317 |
| Abbvie Inc. ABBV | 11 | $241 |
| Madrigal Pharmaceuticals MDGL | 3 | $182 |
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $154 |
| Phathom Pharmaceuticals, Inc. PHAT | 7 | $140 |
| Ardelyx, Inc. ARDX | 4 | $117 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 6 | $112 |
| Aimmune Therapeutics, Inc. | 3 | $85.86 |
| Pfizer Inc. PFE | 3 | $73.66 |
| Gilead Sciences, Inc. GILD | 2 | $47.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.